TNFSF10 and metastatic melanoma: Module 2 is enriched for several carcinogenic signatures, including “top genes down‐regulated in metastatic versus non‐metastatic bladder cancer cell lines” and “genes up‐regulated in primary melanoma, sensitive to TRAIL compared to metastatic melanoma, resistant to TRAIL” (Figure 4F; Table S6).